In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Guest Post by Dario C. Altieri, MD The Wistar Institute
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
Advances against cancer that make it to the clinic are a result of many years of hard work by...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
On Jan. 30, President Obama proposed a $215 million Precision Medicine Initiative, with the goal of revolutionizing medicine. This...
Guest Post by Jonas de Souza, MD The University of Chicago Medicine
Yet more good news emanated from the U. S. Food and Drug Administration (FDA) last week when it announced...
The American Association for Cancer Research is thrilled to announce its 2015 class of fellows of the AACR Academy....
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
Guest Post by Peter A. Jones, PhD, DSc Research Director and Chief Scientific Officer Van Andel Research Institute